Ncardia
Operator of a biotechnology company intended to provide technologies to expedite drug discovery and development processes. The company uses human induced pluripotent stem cells (hiPSCs) technology to ...
Valuation
$174M
Market implied
Share Price
N/A
Total Raised
$129.7M
Last Round
N/A